Tag: Fda warnings

In 2020, the U.S. Food and Drug Administration (FDA) announced recalls for specific lots of extended-release metformin, a standard medication for Type 2 diabetes, due to the presence of a probable human carcinogen. While this was a past event, it highlights the importance of staying informed about medication safety, prompting many to ask: **What is the new warning for metformin?**

According to reports submitted to the FDA, accidental intravenous administration of topical thrombin has resulted in severe, and in some cases, fatal, adverse events. This is because topical thrombin is formulated exclusively for external use on bleeding surfaces, and **can topical thrombin be injected** is a critical question with a life-threatening answer.

The U.S. Food and Drug Administration (FDA) places a boxed warning on Adderall due to its high potential for abuse and dependence, which is one of several significant considerations in determining **who cannot be prescribed Adderall**. The decision rests heavily on a patient's full medical history.

Several studies and U.S. Food and Drug Administration (FDA) warnings have identified a specific class of antibiotics that can increase the risk of a rare but life-threatening event called aortic dissection. This article answers the important question: **What antibiotic can cause aortic dissection?**

Prescriptions for antipsychotics among children and adolescents have doubled in recent years, despite many being used off-label. This raises important questions: is there an age limit for antipsychotics and how does age affect prescribing?

As of 2025, there is no FDA-approved generic version of semaglutide available in the United States. This guide will clarify the crucial difference between FDA-approved semaglutide and unregulated compounded products, detailing the safe and proper way to use this medication.

Reports from the FDA highlight significant concerns regarding the quality of compounded drugs, including semaglutide, with some batches containing incorrect dosages or ingredients. This raises the critical question: Does compounded semaglutide lose its potency over time, and what factors contribute to its stability?

First approved by the FDA in 1996, the antibiotic levofloxacin, once sold under the brand name Levaquin, is a key member of the fluoroquinolone class. If you've ever wondered **what class does levofloxacin belong to?**, the answer is this potent group of broad-spectrum antibiotics known for their ability to treat a variety of serious bacterial infections.

In clinical trials, the active ingredient tirzepatide demonstrated remarkable efficacy for weight loss, with participants achieving up to 22.5% body weight reduction. The question, however, is: does compounded tirzepatide work with the same reliability and safety? The answer involves understanding significant differences in regulation, quality, and formulation.

As of 2025, there is no FDA-approved generic semaglutide available in the United States; the only approved versions are brand-name products like Ozempic, Wegovy, and Rybelsus. Instead of a federally-approved generic, the market saw a rise in compounded semaglutide during shortages, which carry significant risks and are not interchangeable with the regulated, brand-name versions.